Clinical Trial Update: Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

View source ↗

Summary

This clinical trial update notes recruitment for validating Freenome's multiomics blood test as a lung cancer screening tool.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Freenome Holdings Inc. | Conditions: Lung Cancer Diagnosis | Status: RECRUITING